Nursing, ISSN 0360-4039, 05/2018, Volume 48, Issue 5, pp. 61 - 63
Journal Article
Journal of Applied Biobehavioral Research, ISSN 1071-2089, 03/2018, Volume 23, Issue 1, pp. e12129 - n/a
Deaths related to opioids have quadrupled since 1999, making it a top priority in health care. This article will provide an overview of the opioid crisis,...
pain | interdisciplinary care | compliance/adherence issues | Drug abuse | Care and treatment | Nurses
pain | interdisciplinary care | compliance/adherence issues | Drug abuse | Care and treatment | Nurses
Journal Article
Journal of the American Association of Nurse Practitioners, ISSN 2327-6886, 11/2017, Volume 29, Issue 11, pp. 704 - 710
Purpose Opioid medications are integral in managing acute moderate‐to‐severe pain. Opioid analgesics bind to μ (mu), κ (kappa), or δ (delta) opioid receptors...
nurse practitioners | Pain management | pain response | patient outcomes | opioids | nausea | vomiting | ADVANCED CANCER | NURSING | CHEMORECEPTOR TRIGGER ZONE | RANDOMIZED CONTROLLED-TRIAL | PREVENTING POSTOPERATIVE NAUSEA | ANTIEMETIC ACTIVITY | KNEE REPLACEMENT | INDUCED EMESIS | HEALTH CARE SCIENCES & SERVICES | DOUBLE-BLIND | QUALITY-OF-LIFE | CHRONIC NONCANCER PAIN | Analgesics, Opioid - adverse effects | Nausea - therapy | Pain - drug therapy | Pain - physiopathology | Humans | Analgesics, Opioid - therapeutic use | Nausea - physiopathology | Vomiting - therapy | Vomiting - physiopathology | Incidence | Care and treatment | Nurse practitioners | Pain | Opioids | Health care industry | Nausea | Health aspects
nurse practitioners | Pain management | pain response | patient outcomes | opioids | nausea | vomiting | ADVANCED CANCER | NURSING | CHEMORECEPTOR TRIGGER ZONE | RANDOMIZED CONTROLLED-TRIAL | PREVENTING POSTOPERATIVE NAUSEA | ANTIEMETIC ACTIVITY | KNEE REPLACEMENT | INDUCED EMESIS | HEALTH CARE SCIENCES & SERVICES | DOUBLE-BLIND | QUALITY-OF-LIFE | CHRONIC NONCANCER PAIN | Analgesics, Opioid - adverse effects | Nausea - therapy | Pain - drug therapy | Pain - physiopathology | Humans | Analgesics, Opioid - therapeutic use | Nausea - physiopathology | Vomiting - therapy | Vomiting - physiopathology | Incidence | Care and treatment | Nurse practitioners | Pain | Opioids | Health care industry | Nausea | Health aspects
Journal Article
The Nurse Practitioner, ISSN 0361-1817, 06/2016, Volume 41, Issue 6, pp. 18 - 32
Migraine is a debilitating headache disorder that is underdiagnosed and undertreated worldwide, partially attributable to misdiagnosis and expectations of poor...
diagnosis | migraine | chronic migraine | headache management | Treatment Outcome | Migraine Disorders - therapy | Humans | Migraine Disorders - diagnosis | Practice | Care and treatment | Nurse practitioners | Diagnosis | Migraine | Risk factors | PAIN MANAGEMENT
diagnosis | migraine | chronic migraine | headache management | Treatment Outcome | Migraine Disorders - therapy | Humans | Migraine Disorders - diagnosis | Practice | Care and treatment | Nurse practitioners | Diagnosis | Migraine | Risk factors | PAIN MANAGEMENT
Journal Article
The Journal for Nurse Practitioners, ISSN 1555-4155, 03/2016, Volume 12, Issue 3, pp. 174 - 180
Many patients and health care practitioners are unaware that over-the-counter (OTC) analgesics can cause potentially serious adverse effects when used in...
acetaminophen | pain | pain management | adult health | over-the-counter analgesics | NSAIDs | Over-the-counter analgesics | Pain | Acetaminophen | Adult health | Pain management | DRUG | NURSING | ADULTS | Consumer groups | Nurse practitioners | Healthy food | Health care | Health professionals | Toxicity | Liver | Patient care | Over the counter sales | Analgesics | Metabolites | Vomiting | Older people | Nonsteroidal anti-inflammatory drugs | Drug dosages | Enzymes | Aspirin | Narcotics | Mortality | Nausea | Metabolism | Patients | Nonprescription drugs | Abdomen | Prescription drugs | Side effects | Skin | Pharmaceuticals
acetaminophen | pain | pain management | adult health | over-the-counter analgesics | NSAIDs | Over-the-counter analgesics | Pain | Acetaminophen | Adult health | Pain management | DRUG | NURSING | ADULTS | Consumer groups | Nurse practitioners | Healthy food | Health care | Health professionals | Toxicity | Liver | Patient care | Over the counter sales | Analgesics | Metabolites | Vomiting | Older people | Nonsteroidal anti-inflammatory drugs | Drug dosages | Enzymes | Aspirin | Narcotics | Mortality | Nausea | Metabolism | Patients | Nonprescription drugs | Abdomen | Prescription drugs | Side effects | Skin | Pharmaceuticals
Journal Article
6.
Full Text
Postherpetic neuralgia: Epidemiology, pathophysiology, and pain management pharmacology
Journal of Multidisciplinary Healthcare, ISSN 1178-2390, 09/2016, Volume 9, Issue 1, pp. 447 - 454
Herpes zoster, also known as shingles, is a distinctive clinical condition caused by the reactivation of latent varicella zoster (chickenpox) virus following...
Shingles | Postherpetic neuralgia | Herpes zoster | Pregabalin | Gabapentin | Tricyclic antidepressants | Anticonvulsants | Care and treatment | Activities of daily living | Pain | Shingles (Disease) | Neuralgia | Health aspects | Epidemiology | Patient compliance | Evidence-based medicine | Immunization | Chicken pox | Systematic review | Infections | Vaccines | Data bases | Quality of life | Prevention | Restless legs syndrome | Neurology | Suicides & suicide attempts | postherpetic neuralgia | pregabalin | herpes zoster | gabapentin | shingles | tricyclic antidepressants
Shingles | Postherpetic neuralgia | Herpes zoster | Pregabalin | Gabapentin | Tricyclic antidepressants | Anticonvulsants | Care and treatment | Activities of daily living | Pain | Shingles (Disease) | Neuralgia | Health aspects | Epidemiology | Patient compliance | Evidence-based medicine | Immunization | Chicken pox | Systematic review | Infections | Vaccines | Data bases | Quality of life | Prevention | Restless legs syndrome | Neurology | Suicides & suicide attempts | postherpetic neuralgia | pregabalin | herpes zoster | gabapentin | shingles | tricyclic antidepressants
Journal Article
Journal of Multidisciplinary Healthcare, ISSN 1178-2390, 2018, Volume 11, pp. 323 - 332
Despite advances in the treatment of severe intractable pain, opioids remain a critical and appropriate component of treatment. However, abuse, misuse, and...
Abuse-deterrent | Opioid | Misuse | Abuse | Diversion | Drugs | Prescribing | Drug abuse | Care and treatment | Nurse practitioners | Pain | Prescription writing | Opioids | Planning | Patients | Drug approval | Prescription drugs | Substance abuse treatment | Analgesics | Narcotics | Alcohol | Drug overdose | Vital statistics | diversion | abuse | abuse-deterrent | misuse | opioid
Abuse-deterrent | Opioid | Misuse | Abuse | Diversion | Drugs | Prescribing | Drug abuse | Care and treatment | Nurse practitioners | Pain | Prescription writing | Opioids | Planning | Patients | Drug approval | Prescription drugs | Substance abuse treatment | Analgesics | Narcotics | Alcohol | Drug overdose | Vital statistics | diversion | abuse | abuse-deterrent | misuse | opioid
Journal Article
Pain Management Nursing, ISSN 1524-9042, 04/2019, Volume 20, Issue 2, pp. 107 - 112
The current landscape contains conflicting reports regarding the use of medical marijuana, creating fields of misinformation and lack of understanding by...
MARIJUANA | METAANALYSIS | MANAGEMENT | NURSING | CHRONIC NEUROPATHIC PAIN | NURSES | READINESS | Care and treatment | Cannabinoids | Pain | Medical marijuana | Analgesics | Nurses | Phenols | Health care industry
MARIJUANA | METAANALYSIS | MANAGEMENT | NURSING | CHRONIC NEUROPATHIC PAIN | NURSES | READINESS | Care and treatment | Cannabinoids | Pain | Medical marijuana | Analgesics | Nurses | Phenols | Health care industry
Journal Article
Pain Medicine, ISSN 1526-2375, 03/2019, Volume 20, Issue 3, pp. 429 - 433
We, the undersigned, stand as a unified community of stakeholders and key opinion leaders deeply concerned about forced opioid tapering in patients receiving...
MEDICINE, GENERAL & INTERNAL | ANESTHESIOLOGY | Drug abuse | Substance abuse treatment | Narcotics | Opioids | Pain management | Patients rights | Drug dosages | Chronic illnesses
MEDICINE, GENERAL & INTERNAL | ANESTHESIOLOGY | Drug abuse | Substance abuse treatment | Narcotics | Opioids | Pain management | Patients rights | Drug dosages | Chronic illnesses
Journal Article
The Journal for Nurse Practitioners, ISSN 1555-4155, 11/2019, Volume 15, Issue 10, pp. 717 - 724.e1
Migraine is a highly prevalent, disabling neurological disease that significantly affects patients’ quality of life. There are significant unmet needs in the...
calcitonin gene-related peptide (CGRP) | episodic | migraine | chronic | monoclonal antibodies | DIAGNOSIS | TRIGEMINOVASCULAR PATHWAY | RISK-FACTORS | SAFETY | NURSING | BARRIERS | ERENUMAB | ADHERENCE | PATHOPHYSIOLOGY | EPISODIC MIGRAINE | EPIDEMIOLOGY | Prevention | Nervous system diseases | Peptides | Migraine | Monoclonal antibodies | Medicine, Preventive | Preventive health services | Immunoglobulins | Treatment needs | Unmet needs | Misdiagnosis | Headaches | Antibodies | Nervous system | Neuropeptides | Impact tests | Pruritus | Patients | Quality of life | Pain | Questionnaires | Ligands
calcitonin gene-related peptide (CGRP) | episodic | migraine | chronic | monoclonal antibodies | DIAGNOSIS | TRIGEMINOVASCULAR PATHWAY | RISK-FACTORS | SAFETY | NURSING | BARRIERS | ERENUMAB | ADHERENCE | PATHOPHYSIOLOGY | EPISODIC MIGRAINE | EPIDEMIOLOGY | Prevention | Nervous system diseases | Peptides | Migraine | Monoclonal antibodies | Medicine, Preventive | Preventive health services | Immunoglobulins | Treatment needs | Unmet needs | Misdiagnosis | Headaches | Antibodies | Nervous system | Neuropeptides | Impact tests | Pruritus | Patients | Quality of life | Pain | Questionnaires | Ligands
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.